Obesity Speeds Up Alzheimer's Biomarkers by 95%
New research shows obesity can accelerate Alzheimer's disease progression, with blood tests proving more sensitive than brain scans. Discover the crucial link and potential for future treatments.
New research shows obesity can accelerate Alzheimer's disease progression, with blood tests proving more sensitive than brain scans. Discover the crucial link and potential for future treatments.
New research suggests the smell of fatty foods like bacon during pregnancy could predispose children to obesity. Learn about the study's findings and the implications for maternal nutrition.
The WHO urges global action on GLP-1 drugs like Mounjaro, calling for lower prices and wider access to tackle a crisis affecting 2 billion people by 2030. Discover the challenges and potential.
New once-daily pill orforglipron could help people lose up to 10% body weight at lower cost than current weight loss jabs used by 2.5 million Britons.
Donald Trump launches astonishing attack on revolutionary weight-loss injections like Wegovy and Ozempic, branding them the 'fat shot' while claiming natural methods are superior. The former president's controversial health comments spark medical debate.
New NHS data exposes a growing health crisis as West Midlands records highest childhood obesity rates in England, with nearly 1 in 3 Year 6 children clinically obese.
The pharmaceutical weight loss market heats up as Novo Nordisk's blockbuster drugs Wegovy and Ozempic confront serious competition from Eli Lilly's Mounjaro, reshaping diabetes and obesity treatment landscapes.
Groundbreaking research exposes how current food labelling systems are failing British consumers and contributing to rising obesity rates across the UK.
Explosive revelations emerge about Donald Trump's private stance on revolutionary weight loss drugs while new research highlights their massive economic potential.
A mother-of-three died after using unregulated slimming injections purchased online, as experts warn of growing epidemic of dangerous counterfeit medications flooding the UK.
Exclusive analysis reveals England's escalating obesity epidemic with stark regional disparities and concerning patterns emerging across different demographic groups.
Danish pharmaceutical giant Novo Nordisk enters bidding war with Pfizer for obesity biotech firm Metsera, signalling major shift in weight-loss treatment market competition.
New CDC data reveals American obesity rates have hit unprecedented levels, while revolutionary GLP-1 medications like Wegovy and Zepbound show promising results in combating the epidemic.
Law enforcement in Pennsylvania intercepts one of the largest LSD shipments in state history, with thousands of doses hidden in packages from India destined for 'Happy Valley'.
Exclusive analysis reveals how Britain's growing obesity epidemic is pushing the NHS toward an impossible choice between routine care and weight-related treatments as waiting lists hit record highs.
Stanford psychologist reveals how weight-loss drugs like Wegovy create profound mental changes that could revolutionise obesity treatment beyond mere physical transformation.
A sophisticated criminal network that smuggled £68 million worth of cocaine into Britain concealed within commercial gas cylinders has been dismantled, with gang members receiving sentences totalling 141 years.
Groundbreaking obesity medication Wegovy gains Medicaid coverage across multiple American states, marking a significant shift in healthcare policy for weight management treatments.
Groundbreaking research from Lund University shows obesity significantly increases risk for numerous cancers including leukaemia, thyroid and breast cancer, with UK health experts calling for urgent action.
Groundbreaking research exposes how obesity has become the primary driver behind rising cancer rates in older adults, with stark warnings for UK healthcare systems.
Groundbreaking research exposes Australia's alarming obesity divide, with detailed analysis revealing which suburbs are winning and losing the battle of the bulge.
New data reveals America's obesity epidemic has worsened dramatically, with 22 states reaching unprecedented levels. Health experts warn of severe consequences for healthcare systems and national wellbeing.
The NHS is launching an ambitious programme using weight-loss medications like Mounjaro to tackle obesity-related conditions and reduce hospital waiting times across the UK.
Groundbreaking research shows weight loss injections like Wegovy and Ozempic do more than help shed pounds - they're linked to significant reductions in premature death from cancer, heart disease and diabetes.
A young woman's life changed forever after taking a suspected party drug at a night out, leaving her blind and paralysed in a shocking case that highlights the dangers of recreational drugs.
Groundbreaking new research reveals how medications like Ozempic, Wegovy, Mounjaro and Zepbound are creating unprecedented weight loss opportunities this autumn, potentially reshaping public health approaches to obesity nationwide.
Breakthrough research shows Mounjaro users lost significantly more weight than Wegovy patients in head-to-head comparison, potentially reshaping obesity treatment across the UK.
Exclusive: The NHS faces a financial timebomb as new analysis reveals prescribing weight-loss drugs like Wegovy could cost twice the entire current GP prescribing budget, sparking a national rationing debate.
New generation weight-loss medications are doing more than suppress appetite; they're fundamentally altering our psychological and emotional connections to eating, raising profound questions for individuals and society.
New research reveals that GLP-1 weight-loss injections not only aid in shedding pounds but also significantly quiet intrusive thoughts about food, offering a dual benefit for patients.